Market Overview

Merck in Talks to Acquire Cubist for ~$100/Share

Merck in Talks to Acquire Cubist for ~$100/Share

Merck & Co Inc. (NYSE: MRK), is reportedly in talks to acquire Lexington, MA-based Cubist Pharmaceuticals Inc. (NASDAQ: CBST) for around $7.5 billion, or approximately $100 per share according to the NY Times DealBook. A deal could be announced as early as next week, according to persons familiar with the matter.

Cubist shares closed Friday at $74.36, down $0.16.

Posted-In: NY TimesM&A News Rumors


Related Articles (CBST + MRK)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Unusual Call Activity in Amkor Technology

The Orion Flight And Splashdown: What Are People Saying About It?